Eli Lilly Launches Foundayo: A Novel Oral GLP-1 Weight Management Therapy [TheStreet.com]
ROCHE HOLDING LTD S/ADR (RHHBY)
NASDAQ:AMEX Investor Relations:
roche.com/investors.htm
Company Research
Source: TheStreet.com
Following FDA approval on April 1, 2026, the company designed this once-daily oral medication to treat adults managing obesity or overweight conditions accompanied by weight-related medical complexities.Pharmacological Profile and Accessibility Unlike traditional injectable treatments, Foundayo offers significant administration flexibility. Patients can take the oral pill without stringent food or water restrictions, representing a substantial shift in treatment convenience. To distribute the medication efficiently, Eli Lilly currently utilizes LillyDirect alongside various telehealth platforms. Furthermore, the company plans to rapidly expand availability across standard U.S. retail pharmacies. Strategic Pricing Structure Eli Lilly implemented a tiered pricing strategy to maximize patient access to the new therapy. Self-pay patients can obtain the lowest dose starting at $149 per month. Meanwhile, commercially insured individuals utilizing the Foundayo savings card may reduce t
Show less
Read more
Impact Snapshot
Event Time:
RHHBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RHHBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RHHBY alerts
High impacting ROCHE HOLDING LTD S/ADR news events
Weekly update
A roundup of the hottest topics
RHHBY
News
- Roche launches new Elevidys study after feedback from European regulator [Yahoo! Finance]Yahoo! Finance
- Foundation Medicine to Strengthen Monitoring Portfolio with SAGA Diagnostics’ Tumor-Informed Molecular Residual Disease (MRD) PlatformBusiness Wire
- Is Chugai Pharmaceutical (TSE:4519) Still Attractively Priced After Its Strong Multi Year Run [Yahoo! Finance]Yahoo! Finance
- C4 Therapeutics inks new deal with Roche for degrader-antibody conjugates [Seeking Alpha]Seeking Alpha
- Two more pharmaceutical companies, Abbvie and Genentech, to officially launch on TrumpRx [CBS News]CBS News